These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7562946)

  • 1. Synthesis and antiproliferative and antiviral activity of 2'-deoxy-2'-fluoroarabinofuranosyl analogs of the nucleoside antibiotics toyocamycin and sangivamycin.
    Krawczyk SH; Nassiri MR; Kucera LS; Kern ER; Ptak RG; Wotring LL; Drach JC; Townsend LB
    J Med Chem; 1995 Sep; 38(20):4106-14. PubMed ID: 7562946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of non-nucleoside analogs of toyocamycin, sangivamycin, and ++thiosangivamycin: influence of various 7-substituents on antiviral activity.
    Renau TE; Wotring LL; Drach JC; Townsend LB
    J Med Chem; 1996 Feb; 39(4):873-80. PubMed ID: 8632411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, cytotoxicity, and antiviral activity of some acyclic analogues of the pyrrolo[2,3-d]pyrimidine nucleoside antibiotics tubercidin, toyocamycin, and sangivamycin.
    Gupta PK; Daunert S; Nassiri MR; Wotring LL; Drach JC; Townsend LB
    J Med Chem; 1989 Feb; 32(2):402-8. PubMed ID: 2913300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arabinofuranosylpyrrolo[2,3-d]pyrimidines as potential agents for human cytomegalovirus infections.
    Krawczyk SH; Bernier-Rodriguez M; Nassiri MR; Kern ER; Wotring LL; Drach JC; Townsend LB
    J Med Chem; 1990 Dec; 33(12):3160-9. PubMed ID: 2175356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and evaluation of certain thiosangivamycin analogs as potential inhibitors of cell proliferation and human cytomegalovirus.
    Krawczyk SH; Renau TE; Nassiri MR; Westerman AC; Wotring LL; Drach JC; Townsend LB
    J Med Chem; 1995 Sep; 38(20):4115-9. PubMed ID: 7562947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of non-nucleoside analogs of toyocamycin, sangivamycin, and thiosangivamycin: the effect of certain 4- and 4,6-substituents on the antiviral activity of pyrrolo[2,3-d]pyrimidines.
    Renau TE; Kennedy C; Ptak RG; Breitenbach JM; Drach JC; Townsend LB
    J Med Chem; 1996 Aug; 39(18):3470-6. PubMed ID: 8784444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and antiviral activity of some 7-[(2-hydroxyethoxy)methyl]pyrazolo[3,4-d]pyrimidine analogues of sangivamycin and toyocamycin.
    Saxena NK; Coleman LA; Drach JC; Townsend LB
    J Med Chem; 1990 Jul; 33(7):1980-3. PubMed ID: 2163453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, cytotoxicity, and antiviral activity of certain 7-[(2-hydroxyethoxy)methyl]pyrrolo[2,3-d]pyrimidine nucleosides related to toyocamycin and sangivamycin.
    Gupta PK; Nassiri MR; Coleman LA; Wotring LL; Drach JC; Townsend LB
    J Med Chem; 1989 Jul; 32(7):1420-5. PubMed ID: 2500527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleic acid related compounds. 51. Synthesis and biological properties of sugar-modified analogues of the nucleoside antibiotics tubercidin, toyocamycin, sangivamycin, and formycin.
    De Clercq E; Balzarini J; Madej D; Hansske F; Robins MJ
    J Med Chem; 1987 Mar; 30(3):481-6. PubMed ID: 3820218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and antiviral activity of novel 4,5-disubstituted 7-(beta-D-ribofuranosyl)pyrrolo[2,3-d][1,2,3]triazines and the novel 3-amino-5-methyl-1-(beta-D-ribofuranosyl)- and 3-amino-5-methyl-1-(2-deoxy-beta-D-ribofuranosyl)-1,5-dihydro-1,4,5,6,7,8-hexaazaacenaphthylene as analogues of triciribine.
    Migawa MT; Drach JC; Townsend LB
    J Med Chem; 2005 Jun; 48(11):3840-51. PubMed ID: 15916436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and anti-DNA viral activities in vitro of certain 2,4-disubstituted-7-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)pyrrolo[2,3-d d pyrimidine nucleosides.
    Bhattacharya BK; Ojwang JO; Rando RF; Huffman JH; Revankar GR
    J Med Chem; 1995 Sep; 38(20):3957-66. PubMed ID: 7562929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleosides. 110. Synthesis and antiherpes virus activity of some 2'-fluoro-2'-deoxyarabinofuranosylpyrimidine nucleosides.
    Watanabe KA; Reichman U; Hirota K; Lopez C; Fox JJ
    J Med Chem; 1979 Jan; 22(1):21-4. PubMed ID: 218006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and antiproliferative and antiviral activity of carbohydrate-modified pyrrolo[2,3-d]pyridazin-7-one nucleosides.
    Meade EA; Wotring LL; Drach JC; Townsend LB
    J Med Chem; 1997 Feb; 40(5):794-801. PubMed ID: 9057866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological activities of 2'-deoxy-2'-fluoro-4'-thioarabinofuranosylpyrimidine and -purine nucleosides.
    Yoshimura Y; Kitano K; Yamada K; Sakata S; Miura S; Ashida N; Machida H
    Bioorg Med Chem; 2000 Jul; 8(7):1545-58. PubMed ID: 10976503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and antiherpesvirus activities of 5-alkyl-2-thiopyrimidine nucleoside analogues.
    Shigeta S; Mori S; Watanabe F; Takahashi K; Nagata T; Koike N; Wakayama T; Saneyoshi M
    Antivir Chem Chemother; 2002 Mar; 13(2):67-82. PubMed ID: 12238531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, and antiviral evaluation of 2-substituted 4,5-dichloro- and 4,6-dichloro-1-beta-D-ribofuranosylbenzimidazoles as potential agents for human cytomegalovirus infections.
    Zou R; Drach JC; Townsend LB
    J Med Chem; 1997 Feb; 40(5):802-10. PubMed ID: 9057867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyrrolopyrimidine nucleosides. 18. Synthesis and chemotherapeutic activity of 4-amino-7-(3-deoxy-beta-D-ribofuranosyl)pyrrolo[2,3-d] pyrimidine-5-carboxamide (3'-deoxysangivamycin) and 4-amino-7-(2-deoxy-beta-D-ribofuranosyl)pyrrolo[2,3-d] pyrimidine-5-carboxamide (2'-deoxysangivamycin).
    Maruyama T; Wotring LL; Townsend LB
    J Med Chem; 1983 Jan; 26(1):25-9. PubMed ID: 6827526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, and antiviral evaluation of 2-chloro-5,6-dihalo-1-beta-D-ribofuranosylbenzimidazoles as potential agents for human cytomegalovirus infections.
    Zou R; Drach JC; Townsend LB
    J Med Chem; 1997 Feb; 40(5):811-8. PubMed ID: 9057868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, and antiviral activity of alpha-nucleosides: D- and L-isomers of lyxofuranosyl- and (5-deoxylyxofuranosyl)benzimidazoles.
    Migawa MT; Girardet JL; Walker JA; Koszalka GW; Chamberlain SD; Drach JC; Townsend LB
    J Med Chem; 1998 Apr; 41(8):1242-51. PubMed ID: 9575044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of 2',3'-dideoxy-L-pyrimidine nucleosides as potential antiviral agents against human immunodeficiency virus (HIV) and hepatitis B virus (HBV).
    Lin TS; Luo MZ; Liu MC; Pai SB; Dutschman GE; Cheng YC
    J Med Chem; 1994 Mar; 37(6):798-803. PubMed ID: 8145230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.